Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

All-cause mortality across cryptogenic steatotic liver disease and MASLD phenotypes: an NHANES III cohort study.

Created on 17 Nov 2026

Authors

Xuelin Yin, Qiaoyue Ge, Yuqing Liu, Xingxing Li, Chuan Yu, Zhenmi Liu, Chenghan Xiao

Published in

Endocrine. Volume 91. Issue 1. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

The transition from "non-alcoholic fatty liver disease" (NAFLD) to "metabolic dysfunction-associated steatotic liver disease" (MASLD) emphasizes cardiometabolic risk factors (CMRFs) in diagnosis. However, all-cause mortality across cryptogenic steatotic liver disease (SLD) and MASLD phenotypes remains incompletely characterized. We aimed to compare all-cause mortality across cryptogenic SLD, overweight-only MASLD, other MASLD phenotypes, and healthy controls.
We analyzed data from 4,437 participants in the Third National Health and Nutrition Examination Survey (NHANES III). Individuals were classified into cryptogenic SLD, metabolic syndrome-related abnormalities (MSRA)-positive MASLD, overweight-only MASLD (body mass index [BMI] ≥ 25 kg/m² without MSRA), and healthy controls. All-cause mortality risk was assessed using Cox models adjusted for demographic, lifestyle, and clinical covariates. All 12,351 eligible participants were included in an eight-group sensitivity analysis, and a second sensitivity analysis replaced BMI with the weight-adjusted waist index (WWI).
Over a median follow-up of 27.4 years, fully adjusted models showed that lean MSRA-positive MASLD was associated with higher mortality than cryptogenic SLD and overweight-only MASLD, whereas these associations were attenuated for overweight MSRA-positive MASLD. Neither cryptogenic SLD nor overweight-only MASLD differed significantly from healthy controls. The eight-group sensitivity analysis yielded similar findings. However, when WWI replaced BMI, the overweight-only MASLD group had higher mortality than healthy controls.
Lean MSRA-positive MASLD was associated with higher all-cause mortality than cryptogenic SLD and overweight-only MASLD in BMI-based analyses, although some comparisons changed with WWI. These findings may help clinicians consider phenotype-specific differences when assessing mortality risk in SLD.

PMID:
43037802
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement